Development and Validation of a Nomogram for Predicting Obstructive Sleep Apnea in Patients with Pulmonary Arterial Hypertension.
Meixi Hu, Anqi Duan, Zhihua Huang...
https://pubmed.ncbi.nlm.nih.gov/35971464/Actively Recruiting
Led by Chinese Pulmonary Vascular Disease Research Group · Updated on 2026-10-26
480
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting a prospective observational study to understand how obstructive sleep apnea OSA affects patients with pulmonary hypertension. The study aims to explore the prevalence, different types, and predictors of OSA in these patients. It also seeks to evaluate if OSA and related physiological changes impact clinical outcomes such as exercise capacity, hospitalization, and overall mortality. Participants diagnosed with pulmonary hypertension through right heart catheterization will undergo an overnight sleep study using a Level III portable device before leaving the hospital. Sleep data will be reviewed by a certified sleep physician, and patients will be categorized into OSA or non-OSA groups based on their apnea-hypopnea index. Various oxygen-related measures and baseline clinical characteristics, including sleepiness scales, will be collected for analysis. Throughout the study, researchers will monitor participants for clinical worsening events, including reduced exercise ability, worsening functional status, hospitalizations related to pulmonary hypertension, or death. Secondary outcomes include individual components of clinical worsening and mortality tracked at one, three, and five years. The study involves detailed cardiorespiratory assessments and ongoing health monitoring to understand the impact of OSA on pulmonary hypertension outcomes.
CONDITIONS
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
Z
Zhihong Liu, M.D., Ph.D
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chinese Pulmonary Vascular Disease Research Group
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 night
Participants undergo an overnight sleep study using a portable device to assess breathing and oxygen levels during sleep before hospital discharge.
1 visit (in-person)
Duration - Up to 5 years
Participants are monitored over time for clinical worsening events such as reduced exercise capacity, worsening functional class, hospitalizations, or mortality.
Follow-up assessments at 1, 3, and 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Meixi Hu, Anqi Duan, Zhihua Huang...
https://pubmed.ncbi.nlm.nih.gov/35971464/Zhihua Huang, Anqi Duan, Meixi Hu...
https://pubmed.ncbi.nlm.nih.gov/36081323/Anqi Duan, Zhihua Huang, Meixi Hu...
https://pubmed.ncbi.nlm.nih.gov/36395719/Zhihua Huang, Anqi Duan, Zhihui Zhao...
https://pubmed.ncbi.nlm.nih.gov/37984019/Chinese Pulmonary Vascular Disease Research Group
Lead Sponsor